These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17660996)

  • 21. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Chhablani JK
    Am J Ophthalmol; 2010 Nov; 150(5):754-5; author reply 755. PubMed ID: 21036213
    [No Abstract]   [Full Text] [Related]  

  • 22. Photodynamic therapy, ranibizumab, and ranibizumab with photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.
    Rouvas AA; Papakostas TD; Ntouraki A; Douvali M; Vergados I; Ladas ID
    Retina; 2011 Mar; 31(3):464-74. PubMed ID: 20948458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of photodynamic therapy with visudyne for polypoidal choroidal vasculopathy].
    Jin CJ; Zhang Y; Tian Z; Kong N; Zhong XJ; Zhou SB; Wen F; Yan H; Tang SB; Ge J
    Zhonghua Yan Ke Za Zhi; 2007 Jul; 43(7):642-5. PubMed ID: 17897556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.
    Tomita K; Tsujikawa A; Yamashiro K; Ooto S; Tamura H; Otani A; Nakayama Y; Yoshimura N
    Am J Ophthalmol; 2012 Jan; 153(1):68-80.e1. PubMed ID: 21907965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A; Shiraga F; Shiragami C; Ono A; Tenkumo K
    Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe retinal vascular infarction after photodynamic therapy with verteporfin using the standard protocol.
    Koizumi H; Hatanaka H
    Arch Ophthalmol; 2010 Feb; 128(2):259-62. PubMed ID: 20142558
    [No Abstract]   [Full Text] [Related]  

  • 27. [Photodynamic therapy for polypoidal choroidal vasculopathy].
    You J; Guo X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):899-902. PubMed ID: 21946209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study.
    Ruamviboonsuk P; Tadarati M; Vanichvaranont S; Hanutsaha P; Pokawattana N
    Br J Ophthalmol; 2010 Aug; 94(8):1045-51. PubMed ID: 20530656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choroidal infarction following photodynamic therapy with verteporfin.
    Klais CM; Ober MD; Freund KB; Ginsburg LH; Luckie A; Mauget-Faÿsse M; Coscas G; Gross NE; Yannuzzi LA
    Arch Ophthalmol; 2005 Aug; 123(8):1149-53. PubMed ID: 16087856
    [No Abstract]   [Full Text] [Related]  

  • 30. Photodynamic therapy in chronic central serous chorioretinopathy.
    Battaglia Parodi M; Da Pozzo S; Ravalico G
    Retina; 2003 Apr; 23(2):235-7. PubMed ID: 12707605
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombophilia in the occurrence of retinal vascular infarction after photodynamic therapy with verteporfin using the standard protocol.
    Parmeggiani F; Gemmati D; Costagliola C
    Arch Ophthalmol; 2010 Dec; 128(12):1632; author reply 1632-3. PubMed ID: 21149800
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
    Saito M; Iida T; Kano M
    Retina; 2012 Jul; 32(7):1272-9. PubMed ID: 22547209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypoidal choroidal vasculopathy exudation and hemorrhage: results of monthly ranibizumab therapy at one year.
    Kokame GT; Yeung L; Teramoto K; Lai JC; Wee R
    Ophthalmologica; 2014; 231(2):94-102. PubMed ID: 24135557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy: long-term results].
    Saito M; Nagayama D; Iida T
    Nippon Ganka Gakkai Zasshi; 2009 Aug; 113(8):792-9. PubMed ID: 19715154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy.
    Akaza E; Mori R; Yuzawa M
    Retina; 2008 May; 28(5):717-22. PubMed ID: 18463515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin.
    Sayanagi K; Gomi F; Sawa M; Ohji M; Tano Y
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1569-71. PubMed ID: 17437122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of combined photodynamic therapy and intravitreal bevacizumab injection versus photodynamic therapy alone in polypoidal choroidal vasculopathy.
    Kim SJ; Yu HG
    Retina; 2011 Oct; 31(9):1827-34. PubMed ID: 21734621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy.
    Yodoi Y; Tsujikawa A; Kameda T; Otani A; Tamura H; Mandai M; Yoshimura N
    Am J Ophthalmol; 2007 Jun; 143(6):984-994. PubMed ID: 17336913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Tano Y
    Br J Ophthalmol; 2008 Jul; 92(7):936-40. PubMed ID: 18577645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
    Maruko I; Iida T; Sugano Y; Saito M; Sekiryu T
    Am J Ophthalmol; 2011 Apr; 151(4):594-603.e1. PubMed ID: 21295766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.